CAMEO+ eventHEALTH2026-05-06馃嚭馃嚫
Online platform agrees to stop selling GLP-1 drugs to US customers
source: Made-in-China -> target: U.S. customers
On 2026-05-06, the online platform Made-in-China settled with the Connecticut attorney general's office and agreed to stop selling GLP-1 weight-loss medications to customers in the United States. The agreement also requires the platform to remove GLP-1 listings within five days and pay a suspended penalty, according to the attorney general's office.
0.17Significance2.0Magnitude0.2Systemic0.4Market1Articles
Location
ConnecticutConnecticutNorth AmericaUnited StatesNorth America41.603, -73.088
Story Links